Abstract:Abstract Background To observe the medium- and long-term clinical efficacy and safety of radioactive 125 I seed implantation for refractory malignant tumours based on CT-guided 3D template-assisted technique. Methods Twenty-five patients with refractory malignant tumours who underwent radioactive 125 I seed implantation based on CT-guided 3D template-assisted technique were selected. The post-operative adverse reactions were recorded. The number of puncture needles and particles used in the operation, dosimetric parameters, post-operative physical strength scores, and tumour response were statistically analysed. The overall survival time and survival rate were calculated, and the effect and prognosis were assessed. Results 125 I seed implantation was successful in all patients without serious complications. The average number of implanted puncture needles was 17 (19.12 ± 13.00), and the median number of particles was 52 (55.12 ± 32.97). D 90 in the post-operative clinical target volume (CTV) (93.24 ± 15.70 Gy) was slightly lower than that in the pre-operative CTV (93.92 ± 17.60 Gy; P > 0.05). The D 90 in the post-operative planning target volume (PTV) (142.16 ± 22.25 Gy) was lower than the pre-operative PTV (145.32 ± 23.48 Gy; P > 0.05). The tumour responses at 6 months post-operatively: complete remission (CR), 20% (5/25); partial remission (PR), 48% (12/25); stable disease (SD), 24% (6/25); progressive disease (PD), 8% (2/25); CR + PR, 68% (17/25); and local control rate, 92% (23/25). The 6-, 12-, and 24-month survival rates were 100, 88, and 52%, respectively. The post-operative physical strength score (Karnofsky performance score, KPS) exhibited a gradual trend towards recovery, which rose to the highest value 12 months after implantation and then decreased slightly, but the average score was still > 90 points. There was one intra-operative pneumothorax, and two patients with superficial malignant tumours developed skin ulcerations. Multivariate analysis of prognosis showed that tumour sites and types were independent risk factors affecting survival. The number of needles and particles and template types were not the factors. Conclusions 3D template combined with CT-guided radioactive 125 I seed implantation can improve the rational distribution of radiation dose in the tumour target area because accurate radioactive 125 I particle implantation was achieved. This technique has fewer complications and can further extend the overall survival and improve the quality of life. Trial registration Registration number: ChiCTR2000034566 2020/7/10 0:00:00 Retrospectively registered.

Operation Procedure for 125I Seed Brachytherapy in Malignant Solid Tumor of the Abdomen

Iodine-125 seeds placement in tumor for interstitial brachytherapy:value and application of imageology

CT-guided 125I seed implantation for treating abdominal metastatic lymph nodes

Technical procedure of template combined with CT-guided radioactive seeds implantation for lung cancer

~(125)I seeds interstitial brachytherapy for vertebral and paraspinal carcinomas

Expert Consensus Statement on Computed Tomography-Guided 125I Radioactive Seeds Permanent Interstitial Brachytherapy

Expert Consensus on 3D-Printing Template Assisted CT-guided Radioactive 125I Seed Implantation Brachytherapy

Computed Tomography Fluoroscopy-Guided Percutaneous 125I Seed Implantation for Safe, Effective and Real-Time Monitoring Radiotherapy of Inoperable Stage T1-3N0M0 Non-Small-cell Lung Cancer.

Evaluation of radioactive 125I seed implantation for the treatment of refractory malignant tumours based on a CT-guided 3D template-assisted technique: efficacy and safety

Establishment and Short-Term Efficacy of Ultrasound-Guided 125I Seed Interstitial Brachytherapy for Prostatic Carcinoma

CT-guided 125 I Seed Brachytherapy for Abdominal Metastatic Lymph Nodes

CT-guided radioactive 125I seed implantation for the treatment of mediastinal metastases: initial results in 11 patients

Expert consensus statement on computed tomography-guided I-125 radioactive seeds permanent interstitial brachytherapy

Application of digital surgical techniques in radioactive 125I seed implantation for brachytherapy of deep head and neck tumors

Application of radioactive particle interstitial implant brachytherapy in the treatment of malignant adenogenous tumors invaded into cranial base area

[CT Guided Interstitial 125I Seed Implantation Treatment for Head and Neck Malignant Tumor].

Permanent 125I Seeds Implantation in Cancers Report of 85 Cases)

Implantation of Iodine-125 Seed for Head and Neck Carcinoma

CT-guided Interstitial Implantation of ~(125)I Seed for Lung Cancer

Clinical Application of Transperineal ~(125)I-Seed Implantation Guided by Ultrasonography in Prostate Cancer

Interstitial ~(125)I seed implantation in the treatment of metastatic and recurrent bone neoplasms